Condition: Articular Cartilage Defect · Chondral Defect · Osteochondritis · Sponsor: Centre Hospitalier Universitaire Vaudois
This study was aimed to evaluate effectiveness and safety of autologous chondrocyte suspension for treatment of knee articular cartilage defects.
This description comes directly from the study's public registry record.
Robin MARTIN, MD · 021 314 76 79 · robin.martin@chuv.ch
Virginie PHILIPPE, Ph-D · 021 314 90 18 · virginie.philippe@chuv.ch
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire Vaudois - CHUV | Lausanne, Canton of Vaud, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04296487